Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bladder Cancer
Study findings from Herlev University broaden understanding of bladder cancer
November 25th, 2008
According to a study from Denmark, "This Practice Point commentary discusses the paper by Dhar and colleagues, which compared outcomes between two cohorts of patients with muscle-invasive bladder cancer who received either 'limited' pelvic lymph node dissection (LND) or 'extended' pelvic LND at clinics in the US or Switzerland. The patients who received extended LND demonstrated improved overall and recurrence-free survival." "Notably, however, the 'extended' and `limited' dissections utilized in this study do not correspond to the commonly used anatomical templates defined by these terms. Nonetheless, despite this and other methodological limitations, this study does...
Source: Cancer Weekly (2008-11-25)
|
